A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

Ipsen

Status: Completed

Conditions: Growth Hormone Disorders

Study type: Observational

Funder types: Industry

Identifiers

NCT00455884

2-79-58035-006

Details and patient eligibility

About

This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germany, Italy, and United Kingdom

Enrollment: 546 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Growth Hormone Deficiency
• Patients treated with NutropinAq®
• Patients having completed growth (fused epiphyses)

Exclusion criteria

• Active neoplasia
• Pregnancy